fbpx
Learn2Health: Learn about Diabetes and Healthy Meal Planning

New Study for NASH + Type 2 Diabetes Patients. Join to treat liver scarring.

About The Study

This study is for those with Type 2 Diabetes and scarring of the liver due to NASH (non-alcoholic steatohepatitis). NASH is also sometimes called “fatty liver.” Many people have a build-up of fat in the liver, and for most people, it causes no symptoms and no problems. But in some people, the fat causes inflammation and damages cells in the liver. NASH can be caused by conditions such as excess weight or other metabolic conditions when combined with certain diets and genetic backgrounds. Fatty liver is the most common cause of chronic liver disease in North America. There is currently no approved medication to help fatty liver.

Qualified participants in this study will receive a once-weekly investigational injection..

Qualified participants have a 2 out of 3 chance of receiving the study drug, or a 1 out of 3 chance of placebo. The goal of the study is to see if the study drug will help in the treatment of NASH and liver fibrosis.

To take part in the study, participants should be:

  • Diagnosed with NASH (or ‘Fatty Liver’) and fibrosis
  • Between 18 – 80 years old
  • Diagnosed with Type 2 Diabetes
  • Have 2 out of 4 components of metabolic syndrome (obesity, dyslipidemia, elevated blood pressure, elevated fasting glucose)
  • A BMI of 25 and greater
  • Meet other study criteria
See if you qualify
Study Image

What Is a Study?

  • A clinical study helps advance the future of diabetes! Research patients try new meds or devices not yet available to the public, at no cost to them.
  • Research patients meet with a study coordinator and doctor multiple times to monitor them.
  • Each visit, patients are compensated for travel expenses.
  • Study patients must meet a list of criteria in order to be a part of a study.
  • A study can last anywhere from six months to a few years.

Join this study!

If you want to see if you qualify for a study, share your information and we will contact you. Want to speak with someone immediately? Call (515) 329-5690.

Please enter your first name.
Please enter your last name.
Please enter a valid phone number.
Please enter a valid email address.

Benefits


Receive free medications and free supplies!

Gain better understanding of your disease and take an active role in your health.

Obtain treatments not yet available and contribute to medical research.

Travel stipends for attending most scheduled research appointments.

On average patients receives free care worth $250 - $500 from diabetes experts.

So far Iowa Diabetes Research has spent more than $500K on patients benefits

Our Caring Team

Anuj Bhargava

Dr. Anuj Bhargava

CEO and Medical Director

Tara Herrold

Tara Herrold

Director of Clinical Research

Natalie Young

Natalie Young

Clinical Research Coordinator

Kendra Ridenour

Kendra Ridenour

Navigator/Study Start-up Manager

Kara Turner

Kara Turner

Clinical Research Coordinator

Allie Fowler

Allie Bohr

Clinical Research Coordinator

Have questions?

Call us at (515) 329-6800

Email us at info@iowadiabetes.com.